| Iterative in situ click chemistry creates antibody‐like protein‐capture agents HD Agnew, RD Rohde, SW Millward, A Nag, WS Yeo, JE Hein, SM Pitram, ... Angewandte Chemie International Edition 48 (27), 4944-4948, 2009 | 182 | 2009 |
| A general synthetic approach for designing epitope targeted macrocyclic peptide ligands S Das, A Nag, JX Liang, DN Bunck, A Umeda, B Farrow, MB Coppock, ... Angewandte Chemie International Edition 54 (45), 13219-13224, 2015 | 77 | 2015 |
| Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1 SW Millward, RK Henning, GA Kwong, S Pitram, HD Agnew, KM Deyle, ... Journal of the American Chemical Society 133 (45), 18280-18288, 2011 | 65 | 2011 |
| Effects of ion concentration on the hydrogen bonded structure of water in the vicinity of ions in aqueous NaCl solutions A Nag, D Chakraborty, A Chandra Journal of Chemical Sciences 120, 71-77, 2008 | 53 | 2008 |
| In situ click chemistry: from small molecule discovery to synthetic antibodies SW Millward, HD Agnew, B Lai, SS Lee, J Lim, A Nag, S Pitram, R Rohde, ... Integrative Biology 5 (1), 87-95, 2013 | 49 | 2013 |
| Degradation of Akt using protein‐catalyzed capture agents RK Henning, JO Varghese, S Das, A Nag, G Tang, K Tang, ... Journal of Peptide Science 22 (4), 196-200, 2016 | 48 | 2016 |
| Epitope Targeting of Tertiary Protein Structure Enables Target‐Guided Synthesis of a Potent In‐Cell Inhibitor of Botulinum Neurotoxin B Farrow, M Wong, J Malette, B Lai, KM Deyle, S Das, A Nag, HD Agnew, ... Angewandte Chemie 127 (24), 7220-7225, 2015 | 44 | 2015 |
| A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1 KM Deyle, B Farrow, Y Qiao Hee, J Work, M Wong, B Lai, A Umeda, ... Nature chemistry 7 (5), 455-462, 2015 | 37 | 2015 |
| A chemical epitope-targeting strategy for protein capture agents: the serine 474 epitope of the kinase Akt2 A Nag, S Das, MB Yu, KM Deyle, SW Millward, JR Heath Angewandte Chemie (International ed. in English) 52 (52), 13975, 2013 | 37 | 2013 |
| Cyclic peptide binder against oncogenic K-Ras RK Henning, AN Ram, S Das, A Nag, JR Heath US Patent 10,017,540, 2018 | 22 | 2018 |
| Capture agents and related compositions, methods and systems H Agnew, R Rohde, S Millward, A Nag, JR Heath US Patent 9,188,584, 2015 | 16 | 2015 |
| Cyclic peptides as protein targeting agents JR Heath, RD Rohde, A Nag, S Das, A Umeda US Patent 11,168,115, 2021 | 12 | 2021 |
| Fluorescent Sensors of Phosphate Containing Biomolecules A Nag, S Das Israel Journal of Chemistry 61 (3-4), 169-184, 2021 | 9 | 2021 |
| Capture agents and related compositions, methods and systems H Agnew, R Rohde, S Millward, A Nag, JR Heath US Patent 8,906,830, 2014 | 9 | 2014 |
| Akt-specific capture agents, compositions, and methods of using and making JR Heath, A Nag, S Das, KM Deyle, SW Millward, PE Kearney US Patent 9,239,332, 2016 | 8 | 2016 |
| IL-17F-specific capture agents, compositions, and methods of using and making JR Heath, H Agnew, B Farrow, D Bunck, J Liang, A Nag, S Das, BT Lai, ... US Patent 10,598,671, 2020 | 6 | 2020 |
| Facile de Novo Sequencing of Tetrazine‐Cyclized Peptides through UV‐Induced Ring‐Opening and Cleavage from the Solid Phase A Borges, C Nguyen, M Letendre, I Onasenko, R Kandler, NK Nguyen, ... ChemBioChem 24 (4), e202200590, 2023 | 5 | 2023 |
| Cyclic peptide binder against oncogenic K-Ras RK Henning, AN Ram, S Das, A Nag, JR Heath US Patent 10,913,774, 2021 | 4 | 2021 |
| Chemical Epitope Targeting: Review of a Novel Screening Technology AN Qurrat Ul-Ain, Rene Kandler, Dylan Gillespie Journal of Medicinal Chemistry and Drug Design, ISSN 2578-9589 1 (2), 2018 | 4* | 2018 |
| Biological applications of amide and amino acid containing synthetic macrocycles A Borges, D Gillespie, A Nag Supramolecular Chemistry 31 (8), 575-596, 2019 | 3 | 2019 |
Samir DasCalifornia Institute of TechnologyVerified email at caltech.edu
